Global Ipilimumab Market Outlook 2022

SKU ID : QYR-19747624 | Publishing Date : 21-Dec-2021 | No. of pages : 104

Detailed TOC of Global Ipilimumab Market Outlook 2022

1 Ipilimumab Market Overview
    1.1 Product Overview and Scope of Ipilimumab
    1.2 Ipilimumab Segment by Type
        1.2.1 Global Ipilimumab Sales Growth Rate Comparison by Type (2021-2027)
        1.2.2 PD - L1 Antagonists
        1.2.3 CTLA4 Antagonists
        1.2.4 Immunocheckpoint Inhibitors
        1.2.5 Other
    1.3 Ipilimumab Segment by Application
        1.3.1 Global Ipilimumab Sales Comparison by Application: (2021-2027)
        1.3.2 Cancer
        1.3.3 Melanoma
    1.4 Global Ipilimumab Market Size Estimates and Forecasts
        1.4.1 Global Ipilimumab Revenue 2016-2027
        1.4.2 Global Ipilimumab Sales 2016-2027
        1.4.3 Ipilimumab Market Size by Region: 2016 Versus 2021 Versus 2027

2 Ipilimumab Market Competition by Manufacturers
    2.1 Global Ipilimumab Sales Market Share by Manufacturers (2016-2021)
    2.2 Global Ipilimumab Revenue Market Share by Manufacturers (2016-2021)
    2.3 Global Ipilimumab Average Price by Manufacturers (2016-2021)
    2.4 Manufacturers Ipilimumab Manufacturing Sites, Area Served, Product Type
    2.5 Ipilimumab Market Competitive Situation and Trends
        2.5.1 Ipilimumab Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Ipilimumab Players Market Share by Revenue
        2.5.3 Global Ipilimumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Ipilimumab Retrospective Market Scenario by Region
    3.1 Global Ipilimumab Retrospective Market Scenario in Sales by Region: 2016-2021
    3.2 Global Ipilimumab Retrospective Market Scenario in Revenue by Region: 2016-2021
    3.3 North America Ipilimumab Market Facts & Figures by Country
        3.3.1 North America Ipilimumab Sales by Country
        3.3.2 North America Ipilimumab Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Ipilimumab Market Facts & Figures by Country
        3.4.1 Europe Ipilimumab Sales by Country
        3.4.2 Europe Ipilimumab Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Ipilimumab Market Facts & Figures by Region
        3.5.1 Asia Pacific Ipilimumab Sales by Region
        3.5.2 Asia Pacific Ipilimumab Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Ipilimumab Market Facts & Figures by Country
        3.6.1 Latin America Ipilimumab Sales by Country
        3.6.2 Latin America Ipilimumab Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Ipilimumab Market Facts & Figures by Country
        3.7.1 Middle East and Africa Ipilimumab Sales by Country
        3.7.2 Middle East and Africa Ipilimumab Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Ipilimumab Historic Market Analysis by Type
    4.1 Global Ipilimumab Sales Market Share by Type (2016-2021)
    4.2 Global Ipilimumab Revenue Market Share by Type (2016-2021)
    4.3 Global Ipilimumab Price by Type (2016-2021)

5 Global Ipilimumab Historic Market Analysis by Application
    5.1 Global Ipilimumab Sales Market Share by Application (2016-2021)
    5.2 Global Ipilimumab Revenue Market Share by Application (2016-2021)
    5.3 Global Ipilimumab Price by Application (2016-2021)

6 Key Companies Profiled
    6.1 Gilead
        6.1.1 Gilead Corporation Information
        6.1.2 Gilead Description and Business Overview
        6.1.3 Gilead Ipilimumab Sales, Revenue and Gross Margin (2016-2021)
        6.1.4 Gilead Ipilimumab Product Portfolio
        6.1.5 Gilead Recent Developments/Updates
    6.2 BMS
        6.2.1 BMS Corporation Information
        6.2.2 BMS Description and Business Overview
        6.2.3 BMS Ipilimumab Sales, Revenue and Gross Margin (2016-2021)
        6.2.4 BMS Ipilimumab Product Portfolio
        6.2.5 BMS Recent Developments/Updates
    6.3 Ono
        6.3.1 Ono Corporation Information
        6.3.2 Ono Description and Business Overview
        6.3.3 Ono Ipilimumab Sales, Revenue and Gross Margin (2016-2021)
        6.3.4 Ono Ipilimumab Product Portfolio
        6.3.5 Ono Recent Developments/Updates
    6.4 Roche
        6.4.1 Roche Corporation Information
        6.4.2 Roche Description and Business Overview
        6.4.3 Roche Ipilimumab Sales, Revenue and Gross Margin (2016-2021)
        6.4.4 Roche Ipilimumab Product Portfolio
        6.4.5 Roche Recent Developments/Updates
    6.5 Prestige BioPharma
        6.5.1 Prestige BioPharma Corporation Information
        6.5.2 Prestige BioPharma Description and Business Overview
        6.5.3 Prestige BioPharma Ipilimumab Sales, Revenue and Gross Margin (2016-2021)
        6.5.4 Prestige BioPharma Ipilimumab Product Portfolio
        6.5.5 Prestige BioPharma Recent Developments/Updates
    6.6 Avacta
        6.6.1 Avacta Corporation Information
        6.6.2 Avacta Description and Business Overview
        6.6.3 Avacta Ipilimumab Sales, Revenue and Gross Margin (2016-2021)
        6.6.4 Avacta Ipilimumab Product Portfolio
        6.6.5 Avacta Recent Developments/Updates
    6.7 Baxter
        6.6.1 Baxter Corporation Information
        6.6.2 Baxter Description and Business Overview
        6.6.3 Baxter Ipilimumab Sales, Revenue and Gross Margin (2016-2021)
        6.4.4 Baxter Ipilimumab Product Portfolio
        6.7.5 Baxter Recent Developments/Updates
    6.8 Shenyang Sansheng Pharmaceutical
        6.8.1 Shenyang Sansheng Pharmaceutical Corporation Information
        6.8.2 Shenyang Sansheng Pharmaceutical Description and Business Overview
        6.8.3 Shenyang Sansheng Pharmaceutical Ipilimumab Sales, Revenue and Gross Margin (2016-2021)
        6.8.4 Shenyang Sansheng Pharmaceutical Ipilimumab Product Portfolio
        6.8.5 Shenyang Sansheng Pharmaceutical Recent Developments/Updates

7 Ipilimumab Manufacturing Cost Analysis
    7.1 Ipilimumab Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Ipilimumab
    7.4 Ipilimumab Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Ipilimumab Distributors List
    8.3 Ipilimumab Customers

9 Ipilimumab Market Dynamics
    9.1 Ipilimumab Industry Trends
    9.2 Ipilimumab Growth Drivers
    9.3 Ipilimumab Market Challenges
    9.4 Ipilimumab Market Restraints

10 Global Market Forecast
    10.1 Ipilimumab Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Ipilimumab by Type (2022-2027)
        10.1.2 Global Forecasted Revenue of Ipilimumab by Type (2022-2027)
    10.2 Ipilimumab Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Ipilimumab by Application (2022-2027)
        10.2.2 Global Forecasted Revenue of Ipilimumab by Application (2022-2027)
    10.3 Ipilimumab Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Ipilimumab by Region (2022-2027)
        10.3.2 Global Forecasted Revenue of Ipilimumab by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Figures, Tables and Charts Available in Global Ipilimumab Market Outlook 2022

List of Tables
    Table 1. Global Ipilimumab Sales (KG) Growth Rate Comparison by Type (2021-2027)
    Table 2. Global Ipilimumab Sales (KG) Comparison by Application (2021-2027)
    Table 3. Global Ipilimumab Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
    Table 4. Key Manufacturers Ipilimumab Covered in This Study
    Table 5. Global Ipilimumab Sales (KG) of Key Manufacturers (2016-2021)
    Table 6. Global Ipilimumab Sales Market Share by Manufacturers (2016-2021)
    Table 7. Global Ipilimumab Revenue (US$ Million) by Manufacturers (2016-2021)
    Table 8. Global Ipilimumab Revenue Share by Manufacturers (2016-2021)
    Table 9. Global Market Ipilimumab Average Price (US$/G) of Key Manufacturers (2016-2021)
    Table 10. Manufacturers Ipilimumab Manufacturing Sites and Area Served
    Table 11. Manufacturers Ipilimumab Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Ipilimumab by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ipilimumab as of 2020)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Ipilimumab Sales by Region (2016-2021) & (KG)
    Table 16. Global Ipilimumab Sales Market Share by Region (2016-2021)
    Table 17. Global Ipilimumab Revenue by Region (2016-2021) & (US$ Million)
    Table 18. North America Ipilimumab Sales by Country (2016-2021) & (KG)
    Table 19. North America Ipilimumab Sales Market Share by Country (2016-2021)
    Table 20. North America Ipilimumab Revenue by Country (2016-2021) & (US$ Million)
    Table 21. North America Ipilimumab Revenue Market Share by Country (2016-2021)
    Table 22. Europe Ipilimumab Sales by Country (2016-2021) & (KG)
    Table 23. Europe Ipilimumab Sales Market Share by Country (2016-2021)
    Table 24. Europe Ipilimumab Revenue by Country (2016-2021) & (US$ Million)
    Table 25. Europe Ipilimumab Revenue Market Share by Country (2016-2021)
    Table 26. Asia Pacific Ipilimumab Sales by Region (2016-2021) & (KG)
    Table 27. Asia Pacific Ipilimumab Sales Market Share by Region (2016-2021)
    Table 28. Asia Pacific Ipilimumab Revenue by Region (2016-2021) & (US$ Million)
    Table 29. Asia Pacific Ipilimumab Revenue Market Share by Region (2016-2021)
    Table 30. Latin America Ipilimumab Sales by Country (2016-2021) & (KG)
    Table 31. Latin America Ipilimumab Sales Market Share by Country (2016-2021)
    Table 32. Latin America Ipilimumab Revenue by Country (2016-2021) & (US$ Million)
    Table 33. Latin America Ipilimumab Revenue Market Share by Country (2016-2021)
    Table 34. Middle East and Africa Ipilimumab Sales by Country (2016-2021) & (KG)
    Table 35. Middle East and Africa Ipilimumab Sales Market Share by Country (2016-2021)
    Table 36. Middle East and Africa Ipilimumab Revenue by Country (2016-2021) & (US$ Million)
    Table 37. Middle East and Africa Ipilimumab Revenue Market Share by Country (2016-2021)
    Table 38. Global Ipilimumab Sales (KG) by Type (2016-2021)
    Table 39. Global Ipilimumab Sales Market Share by Type (2016-2021)
    Table 40. Global Ipilimumab Revenue (Million US$) by Type (2016-2021)
    Table 41. Global Ipilimumab Revenue Share by Type (2016-2021)
    Table 42. Global Ipilimumab Price (US$/G) by Type (2016-2021)
    Table 43. Global Ipilimumab Sales (KG) by Application (2016-2021)
    Table 44. Global Ipilimumab Sales Market Share by Application (2016-2021)
    Table 45. Global Ipilimumab Revenue (Million US$) by Application (2016-2021)
    Table 46. Global Ipilimumab Revenue Share by Application (2016-2021)
    Table 47. Global Ipilimumab Price (US$/G) by Application (2016-2021)
    Table 48. Gilead Corporation Information
    Table 49. Gilead Description and Business Overview
    Table 50. Gilead Ipilimumab Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021)
    Table 51. Gilead Ipilimumab Product
    Table 52. Gilead Recent Developments/Updates
    Table 53. BMS Corporation Information
    Table 54. BMS Description and Business Overview
    Table 55. BMS Ipilimumab Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021)
    Table 56. BMS Ipilimumab Product
    Table 57. BMS Recent Developments/Updates
    Table 58. Ono Corporation Information
    Table 59. Ono Description and Business Overview
    Table 60. Ono Ipilimumab Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021)
    Table 61. Ono Ipilimumab Product
    Table 62. Ono Recent Developments/Updates
    Table 63. Roche Corporation Information
    Table 64. Roche Description and Business Overview
    Table 65. Roche Ipilimumab Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021)
    Table 66. Roche Ipilimumab Product
    Table 67. Roche Recent Developments/Updates
    Table 68. Prestige BioPharma Corporation Information
    Table 69. Prestige BioPharma Description and Business Overview
    Table 70. Prestige BioPharma Ipilimumab Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021)
    Table 71. Prestige BioPharma Ipilimumab Product
    Table 72. Prestige BioPharma Recent Developments/Updates
    Table 73. Avacta Corporation Information
    Table 74. Avacta Description and Business Overview
    Table 75. Avacta Ipilimumab Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021)
    Table 76. Avacta Ipilimumab Product
    Table 77. Avacta Recent Developments/Updates
    Table 78. Baxter Corporation Information
    Table 79. Baxter Description and Business Overview
    Table 80. Baxter Ipilimumab Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021)
    Table 81. Baxter Ipilimumab Product
    Table 82. Baxter Recent Developments/Updates
    Table 83. Shenyang Sansheng Pharmaceutical Corporation Information
    Table 84. Shenyang Sansheng Pharmaceutical Description and Business Overview
    Table 85. Shenyang Sansheng Pharmaceutical Ipilimumab Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021)
    Table 86. Shenyang Sansheng Pharmaceutical Ipilimumab Product
    Table 87. Shenyang Sansheng Pharmaceutical Recent Developments/Updates
    Table 88. Production Base and Market Concentration Rate of Raw Material
    Table 89. Key Suppliers of Raw Materials
    Table 90. Ipilimumab Distributors List
    Table 91. Ipilimumab Customers List
    Table 92. Ipilimumab Market Trends
    Table 93. Ipilimumab Growth Drivers
    Table 94. Ipilimumab Market Challenges
    Table 95. Ipilimumab Market Restraints
    Table 96. Global Ipilimumab Sales Forecast by Type (2022-2027) & (KG)
    Table 97. Global Ipilimumab Sales Market Share Forecast by Type (2022-2027)
    Table 98. Global Ipilimumab Revenue Forecast by Type (2022-2027) & (US$ Million)
    Table 99. Global Ipilimumab Revenue Market Share Forecast by Type (2022-2027)
    Table 100. Global Ipilimumab Sales Forecast by Application (2022-2027) & (KG)
    Table 101. Global Ipilimumab Sales Market Share Forecast by Application (2022-2027)
    Table 102. Global Ipilimumab Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 103. Global Ipilimumab Revenue Market Share Forecast by Application (2022-2027)
    Table 104. Global Ipilimumab Sales Forecast by Region (2022-2027) & (KG)
    Table 105. Global Ipilimumab Sales Market Share Forecast by Region (2022-2027)
    Table 106. Global Ipilimumab Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 107. Global Ipilimumab Revenue Market Share Forecast by Region (2022-2027)
    Table 108. Research Programs/Design for This Report
    Table 109. Key Data Information from Secondary Sources
    Table 110. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Ipilimumab
    Figure 2. Global Ipilimumab Market Share by Type in 2020 & 2027
    Figure 3. PD - L1 Antagonists Product Picture
    Figure 4. CTLA4 Antagonists Product Picture
    Figure 5. Immunocheckpoint Inhibitors Product Picture
    Figure 6. Other Product Picture
    Figure 7. Global Ipilimumab Market Share by Application in 2020 & 2027
    Figure 8. Cancer
    Figure 9. Melanoma
    Figure 10. Global Ipilimumab Revenue, (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Ipilimumab Market Size 2016-2027 (US$ Million)
    Figure 12. Global Ipilimumab Sales 2016-2027 (KG)
    Figure 13. Global Ipilimumab Market Size Market Share by Region: 2016 VS 20210 VS 2027
    Figure 14. Ipilimumab Sales Share by Manufacturers in 2020
    Figure 15. Global Ipilimumab Revenue Share by Manufacturers in 2020
    Figure 16. The Global 5 and 10 Largest Ipilimumab Players: Market Share by Revenue in 2020
    Figure 17. Ipilimumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
    Figure 18. Global Ipilimumab Sales Market Share by Region (2016-2021)
    Figure 19. Global Ipilimumab Sales Market Share by Region in 2020
    Figure 20. Global Ipilimumab Revenue Market Share by Region (2016-2021)
    Figure 21. Global Ipilimumab Revenue Market Share by Region in 2020
    Figure 22. U.S. Ipilimumab Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 23. Canada Ipilimumab Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 24. Germany Ipilimumab Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 25. France Ipilimumab Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 26. U.K. Ipilimumab Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 27. Italy Ipilimumab Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 28. Russia Ipilimumab Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 29. China Ipilimumab Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 30. Japan Ipilimumab Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 31. South Korea Ipilimumab Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 32. India Ipilimumab Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 33. Australia Ipilimumab Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 34. Taiwan Ipilimumab Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 35. Indonesia Ipilimumab Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 36. Thailand Ipilimumab Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 37. Malaysia Ipilimumab Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 38. Philippines Ipilimumab Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 39. Vietnam Ipilimumab Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 40. Mexico Ipilimumab Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 41. Brazil Ipilimumab Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 42. Argentina Ipilimumab Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 43. Turkey Ipilimumab Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 44. Saudi Arabia Ipilimumab Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 45. UAE Ipilimumab Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 46. Sales Market Share of Ipilimumab by Type (2016-2021)
    Figure 47. Sales Market Share of Ipilimumab by Application (2016-2021)
    Figure 48. Sales Market Share of Ipilimumab by Application in 2020
    Figure 49. Revenue Share of Ipilimumab by Application (2016-2021)
    Figure 50. Revenue Share of Ipilimumab by Application in 2020
    Figure 51. Manufacturing Cost Structure of Ipilimumab
    Figure 52. Manufacturing Process Analysis of Ipilimumab
    Figure 53. Ipilimumab Industrial Chain Analysis
    Figure 54. Channels of Distribution
    Figure 55. Distributors Profiles
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
    Figure 58. Key Executives Interviewed